The objective of the present study was to investigate the frequency of oral leukoplakia and oral erythroplakia among young patients from three Brazilian reference centers in Oral and Maxillofacial Pathology. A retrospective study was carried out from 2011 to 2021 on 861 patients diagnosed with oral leukoplakia and oral erythroplakia. Demographic and clinicopathological data were evaluated. Fisher’s exact test was used to evaluate the association among sex, age, anatomical location, and histopathological diagnosis. A total of 83 (9.64%) cases involved young patients (aged 0.05). Oral leukoplakia and oral erythroplakia are uncommon diseases in young patients. In this population, oral leukoplakia shows a slight predilection for women aged between 30 and 39 years.
Objective: This review aimed to: (i) identify the variables used by oral medicine services (OMS) to describe the scope of their clinical practices and (ii) identify gaps in the availability of these variables in the literature to guide future research on the characterisation of OM practices. To address the following question: What characteristics from studies on clinical practice have been used to describe the scope of practice in OM? Material and Methods: This scoping review followed the PRISMA‐ScR guidelines. Electronic searches were conducted in the following databases: PubMed, Scopus, Embase, Web of Science, LILACS and grey literature. The presence of the following variables was assessed: referral source, age, sex, medical profile, diagnosis, procedures and follow‐up. Results: A total of 12 studies met the eligibility criteria, comprising 15 OMS across 10 countries and including 114,971 patients. Some studies specifically aimed to characterise OMS practice, while others focused on specific aspects of these practices. Most studies examined variables such as referral source, age, sex and diagnosis. Conclusions: There are gaps in the description of the OMS scope of practice in the literature, particularly regarding patient follow‐up, characterisation of the range of procedures performed and documentation of patients' medical profiles.
21 February 2026 in Oral and Maxillofacial Surgery
Purpose: This systematic review aimed to synthesize the available clinicopathological data on nasopalatine duct cyst (NPDC). Methods: Electronic searches were performed in seven databases and the grey literature, according to the PRISMA 2020 statement. Risk of bias was assessed using the Joanna Briggs Institute critical appraisal tool. Data were analysed using descriptive statistics. Results: A total of 168 studies comprising 2,734 NPDC cases were included. Most lesions were asymptomatic ( n = 358/54.16%) and occurred in males ( n = 1641/60.75%), with individuals in the fourth and fifth decade of life being the most frequently affected. Periapical radiographs ( n = 181/40.31%) and computed tomography scan ( n = 159/35.41%) were the most commonly used imaging modalities. Metaplasia ( n = 278/58.28%) was observed in most cases with a predominance of combinations involving stratified squamous epithelium and pseudostratified ciliated columnar epithelium ( n = 78/47.27%). The periapical cyst was the second most frequent clinical diagnostic hypothesis. Enucleation was the preferred treatment modality ( n = 544/95.94%), and recurrence was absent in most cases ( n = 375/93.05%). Conclusion: NPDC is a benign lesion with a heterogeneous clinical presentation and a low recurrence rate. Its anatomical location frequently results in diagnostic overlap with odontogenic lesions, particularly periapical chronic lesions. Clinicians should be aware of its clinicopathological features and integrate clinical, radiographic, and histopathological findings to ensure accurate diagnosis and appropriate management.
Purpose: To assess the features of the 100 most-cited articles on adjunctive therapy strategies for Medication-Related Osteonecrosis of the Jaw (MRONJ). Methods: The 100 most-cited articles related to adjunctive therapies for MRONJ were collected from the Web of Science. The following information was extracted from the papers: authorship, title of the paper, number of citations, the publication’s year and country, study design, journal title and impact factor, and adjunctive therapy strategies. Temporal distribution of the identified therapies was also analyzed. Results: The 100 articles received a total of 6,095 citations over an 18-year period, with a notable concentration of publications from Italy. Most were descriptive observational studies, published in 55 different journals with impact factors ranging from 0.3 to 41.9. A total of 24 distinct adjunctive therapies were identified. Light-based therapies were the most prominent category ( n = 35/28.9%), encompassing photobiomodulation, laser ablation, and antimicrobial photodynamic therapy. Notably, photobiomodulation showed consistent representation throughout the entire study period, reflecting sustained interest in this modality. Conclusion: The wide range of adjunctive therapies underscores the complexity of MRONJ management. Light-based therapies were the most prominent category identified, highlighting the relevance of laser-based approaches in MRONJ management. However, higher-quality evidence is required, particularly well-designed randomized clinical trials, to clarify the clinical applicability of adjunctive therapies in MRONJ.